Fig 1: siRNAs targeting HDAC5 or HDAC9, but not other class-IIa HDAC family members HDAC4 or HDAC7, promote neurite growth in SH-SY5Y cells. (A) Representative photomicrographs of SH-SY5Y cells immunocytochemically stained for HDAC5 (red) or HDAC9 (red) with DAPI (blue). Scale bar = 10 μm. (B) Representative photomicrographs of SH-SY5Y cells and (C) graph of neurite length at 24, 48, and 72 h post-transfection with 25 nM of a scrambled siRNA (siSCR) or siRNAs against the four class-IIa HDACs (siHDAC4, siHDAC5, siHDAC7, siHDAC9). Scale bar = 50 μm. Data are mean ± SEM as percentage of the siSCR control of n = 3 independent experiments. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. siSCR group; two-way ANOVA with post hoc Tukey’s test. (D) Immunocytochemistry showing nuclear localization of mutant HDAC5-S259A/S498A which is retained in the nucleus. Graphs of (E) AcH3-K9.K14 levels and (F,G) neurite length of SH-SH5Y cells at 72 h post-transfection with a control plasmid (GFP) or plasmids expressing wild-type (WT) HDAC5 or mutant HDAC5-S259A/S498A. Scale bar = 100 μm. Data are presented as the mean ± SEM as a percentage of the GFP control of n = 3 independent experiments. ∗p < 0.05 vs. Control; one-way ANOVA with post hoc Fishers LSD test.
Fig 2: MMP13-ablation alters dentin phenotype, reducing volume and density. (A) Comparative histological analysis of representative sagittal sections of maxillary first molars from Mmp13 −/− and WT mice at postnatal 3-week, 6-week, and 3-months. (a–f) H&E staining demonstrates the altered dentin structure. Analysis of WT (a, c, e) and Mmp13 −/− (b, d, f) mouse molars at 3-week, 6-week, and 3-month highlights progressively altered the dental phenotype including alterations in dentin tubule regularity, disruption of odontoblast layer organization and palisade (d–h. black arrow), narrowing of the predentin layer (indicated sketched white lines in a, c, e), and reduced reactionary dentin formation (ci, ei. [inset] small white arrows). a–f represent higher magnification of distal cusp (inset; ai–fi). Scale bars = (ai–fi) 20 μm (original mag. ×20); (a–f) 10 μm (original mag. x63). (B) Reactionary dentinogenesis was analyzed in 6-week and 3-month maxillary first molar teeth of WT and Mmp13 −/− mice using H&E staining of sagittal sections. Reactionary dentin is reduced after MMP13-ablation (Bb, Bd—white arrows) compared with WT (Ba, Bc—white encircled areas; Ca—white arrow). Multiple pulpal calcifications identified in 3-month Mmp13 −/− molars ((Cb)—white arrows; (Cc)—black arrows). Positive staining for HDAC5 highlights pulpal mineral to be cemental- or bone-like rather than dentin-like in nature with no evident tubular structure (Cc—black arrow). Scale bars = (Ba, Bb, cc) 20 μm (original mag. ×20); (Bc, Bd) 16 μm (original mag. ×20); (Ca, Cb) 50 μm (original mag. ×10). Pp, pulp tissue; Dn, dentin. Sections were examined from six mice per genotype at postnatal 3-week and 6-week and nine mice per genotype at 12-week.
Fig 3: (Acetyl-) Histone H3 and histone deacetylase-5 protein expression following LMK-235 treatment. (A) Levels of acetyl-histone H3, histone H3, and HDAC5 were evaluated by immunoblotting after LMK-235 incubation for 24 h, as shown by one representative example blot. β-actin was used as a loading control for each sample. The β-actin expression corresponding to the HDAC5 blot is not shown. (B,C): Bars represent the semi-quantitative expression as mean values ± SEM (n = 3) of band intensities of BON-1 (B) and QGP-1 (C) cells. Abbreviations: UTC = untreated control.
Fig 4: METTL3 silencing suppressed OS proliferation in vivo via the HDAC5/miR-142-5p/ARMC8 axis.The xenograft tumor model in nude mice was established with U2OS cells stably low-expressing METTL3. A Tumor volume recorded every week. B After the nude mice were euthanized on the 35th day, the tumor weight and representative images were presented. C The positive rate of Ki67 was detected using immunohistochemistry. D, E METTL3 level was determined using RT-qPCR and immunohistochemistry. F m6A level was quantitatively analyzed. G, H HDAC5 level was determined using RT-qPCR and immunohistochemistry. I, J miR-142-5p and ARMC8 level was determined using RT-qPCR. K ARMC8 level was detected using immunohistochemistry. N = 6. The cell experiment was repeated three times independently. Data in panels A–C/E, F/H are presented as mean ± standard deviation. Data in panels B–K were analyzed using t-test. Data in panel A were analyzed using two-way ANOVA, followed by Tukey’s multiple comparisons test, **p < 0.01.
Fig 5: HDAC5 knockdown inhibits TGF-β1-induced HSF activation. (A) Identification of shHDAC5 efficiency in HSFs. (B) EdU (green) proliferation assay for cultured HSFs after incubation with TGF-β1 for 24 h. (Scale bar = 100 µm). (C) Images and quantification of immunofluorescence staining for α-SMA in different groups. α-SMA is labeled in green. (Scale bar = 50 µm). (D) Images and quantification of wound healing assays in different groups 12 h after the addition of TGF-β1. (E) Images and quantification of collagen gel contraction assays in different groups on Day 3 after TGF-β1 addition. Dashed lines indicate the areas of collagen gel. (F) The protein levels of collagen I and III in HSFs pretreated with TGF-β1 for 24 h. Data are presented as the means with SEs (n = 3 independent experiments). *P < 0.05, **P < 0.01, ***P < 0.001, NS = not significant.
Supplier Page from Abcam for Anti-HDAC5 antibody